Orion Biotech Opportunities Corp. (ORIAU) Prices $200M IPO
Orion Biotech Opportunities Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIAU” Thursday, May 13.
The new SPAC aims to combine with a North American, European or Asian healthcare company with a biotech focus. ...READ MORE
